Live CoolSculpting® Demonstration at ASAPS 2013
April 12 2013 - 8:00AM
Business Wire
ZELTIQ® Aesthetics, Inc. (Nasdaq: ZLTQ), a medical
technology company focused on developing and commercializing
products utilizing its proprietary controlled-cooling technology
platform, today announced it is exhibiting at the American Society
for Aesthetic Surgery (ASAPS) in New York, April 11-16, 2013.
CoolSculpting, developed by ZELTIQ, is a non-surgical, clinically
proven procedure designed to selectively reduce fat in treated
areas using a patented cooling technology. Live CoolSculpting
treatments will be performed in the ZELTIQ booth at noon on all
three exhibit days. In addition, patient assessments will be
demonstrated every hour on the hour, 10 a.m. to 4 p.m., on all
three exhibit days. The assessments will focus on “Treatment to
Transformation,” an advanced CoolSculpting concept designed to
promote global patient assessment to address all potential
treatment areas and then recommend the appropriate treatment plan
to consistently achieve the desired results. In the United States,
CoolSculpting is cleared for non-invasive fat reduction of the
abdomen and flank.
WHAT:
CoolSculpting ZELTIQ Booth #1029
WHEN:
ASAPS Exhibit Hours Saturday, April 13, 2013, 9:00 am – 4:30 p.m.
Sunday, April 14, 2013, 9:00 am – 4:30 p.m. Monday, April 15, 2013,
9:00 am – 4:30 p.m.
WHERE:
American Society for Aesthetic Surgery (ASAPS) Annual Conference
Jacob Javits Convention Center 655 West 34th Street New York, NY
10001
About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ’s first commercial
product, the CoolSculpting System, is designed to selectively
reduce stubborn fat that may not respond to diet or exercise.
CoolSculpting is based on the scientific principle that fat cells
are more sensitive to cold than the overlying skin and surrounding
tissues. It utilizes patented technology of precisely controlled
cooling to reduce the temperature of fat cells in the treated area,
which is intended to cause fat cell elimination through a natural
biological process known as apoptosis. ZELTIQ developed
CoolSculpting to safely, noticeably and measurably reduce the fat
layer.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024